Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$676,156
+$44,783 QoQ
Shares Held
2,687
-7.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#2,914
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stockman Wealth Management, Inc. holds $51,758,933 across 8 Drug Manufacturers - General names. ABBV ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
169,661 | $21,801,438 | |
| 2 | GSK |
GSK plc
|
264,689 | $13,874,997 | |
| 3 | PFE |
Pfizer Inc
|
465,614 | $11,211,985 | |
| 4 | LLY |
ELI LILLY & Co
|
1,454 | $1,743,971 | |
| 5 | AZN |
Astrazeneca PLC
|
5,841 | $1,107,570 | |
| 6 | JNJ |
Johnson & Johnson
|
4,255 | $1,080,642 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
2,687 | $676,156 | |
| 8 | AMGN |
Amgen Inc
|
724 | $262,174 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $676,156 | 2,687 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $631,373 | 2,903 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $643,656 | 2,817 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $539,025 | 2,328 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $420,800 | 2,267 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $503,895 | 2,405 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $416,351 | 2,343 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $517,200 | 2,619 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $508,385 | 2,964 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $522,080 | 2,867 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $426,942 | 2,755 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $433,913 | 2,911 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $625,955 | 4,646 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $7,629,520 | 47,873 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $7,909,839 | 48,944 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $6,817,062 | 50,794 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $7,552,625 | 49,312 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $8,015,853 | 49,447 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $7,389,184 | 54,573 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $5,921,847 | 54,898 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $6,035,701 | 53,584 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,202,568 | 48,074 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $5,137,521 | 47,947 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,925,536 | 56,234 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $5,546,188 | 56,490 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $4,685,227 | 61,494 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||